IRIS
GIORDANO, ANTONINO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.301
NA - Nord America 1.205
AS - Asia 952
SA - Sud America 142
Continente sconosciuto - Info sul continente non disponibili 86
AF - Africa 30
OC - Oceania 4
Totale 3.720
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.124
RU - Federazione Russa 629
SG - Singapore 395
IT - Italia 337
CN - Cina 251
BR - Brasile 112
VN - Vietnam 86
HK - Hong Kong 82
SE - Svezia 81
DE - Germania 64
FR - Francia 51
GB - Regno Unito 48
CA - Canada 43
IN - India 34
BD - Bangladesh 25
FI - Finlandia 22
AR - Argentina 14
AT - Austria 13
MX - Messico 13
TR - Turchia 11
ZA - Sudafrica 11
TW - Taiwan 10
ES - Italia 9
JP - Giappone 9
NL - Olanda 9
PL - Polonia 9
IR - Iran 8
IE - Irlanda 7
VE - Venezuela 7
BE - Belgio 6
ID - Indonesia 6
GT - Guatemala 5
MA - Marocco 5
MY - Malesia 5
QA - Qatar 5
AU - Australia 4
EG - Egitto 4
IL - Israele 4
IQ - Iraq 4
KE - Kenya 4
NI - Nicaragua 4
SA - Arabia Saudita 4
CR - Costa Rica 3
EC - Ecuador 3
ET - Etiopia 3
SV - El Salvador 3
TH - Thailandia 3
AE - Emirati Arabi Uniti 2
CH - Svizzera 2
CL - Cile 2
CO - Colombia 2
DO - Repubblica Dominicana 2
JM - Giamaica 2
LT - Lituania 2
RO - Romania 2
SI - Slovenia 2
UA - Ucraina 2
UZ - Uzbekistan 2
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
EU - Europa 1
GD - Grenada 1
GP - Guadalupe 1
HN - Honduras 1
HT - Haiti 1
JO - Giordania 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
LY - Libia 1
NO - Norvegia 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
PR - Porto Rico 1
PT - Portogallo 1
SY - Repubblica araba siriana 1
UG - Uganda 1
UY - Uruguay 1
Totale 3.635
Salva come PNG Salva come JPEG
Città #
Singapore 242
Ashburn 156
San Jose 129
Moscow 117
Dallas 112
Milan 88
Hong Kong 80
Beijing 66
Council Bluffs 49
Shanghai 40
New York 38
Ho Chi Minh City 32
Hefei 29
Los Angeles 29
Munich 29
Lauterbourg 26
Orem 26
Phoenix 26
Hanoi 22
Rome 21
Santa Clara 21
Boardman 20
Denver 15
Princeton 15
Carrboro 14
Lawrence 14
Frankfurt am Main 13
São Paulo 13
Chennai 12
Montreal 12
Atlanta 11
Turku 11
Boston 10
Houston 10
London 10
Johannesburg 9
Manchester 9
Stockholm 9
Tokyo 9
Catania 8
Helsinki 8
North Bergen 8
Palermo 8
Warsaw 8
Dublin 7
Mexico City 7
Naples 7
Barnet 6
Brooklyn 6
Buffalo 6
Da Nang 6
Dhaka 6
Florence 6
Nuremberg 6
Omaha 6
Poplar 6
Sala 6
Toronto 6
Vienna 6
Ankara 5
Bologna 5
Chicago 5
Doha 5
Miano 5
Mumbai 5
Cagliari 4
Guatemala City 4
Istanbul 4
Managua 4
Philadelphia 4
Pittsburgh 4
Pune 4
Seattle 4
Shenzhen 4
Taoyuan 4
Addis Ababa 3
Amsterdam 3
Bari 3
Bergamo 3
Betim 3
Brasília 3
Etobicoke 3
Ferrara 3
Marino 3
Miami 3
Nairobi 3
Newark 3
Paris 3
Piscataway 3
Queens 3
Rio de Janeiro 3
San Francisco 3
San Salvador 3
Taranto 3
Tehran 3
Vaprio d'Adda 3
Vicenza 3
Washington 3
Abu Dhabi 2
Alexandria 2
Totale 1.870
Salva come PNG Salva come JPEG
Nome #
A molecular and environmental approach to dissect disease heterogeneity in multiple sclerosis 339
Correction to: Pharmacogenomics of clinical response to Natalizumab in multiple sclerosis: a genome-wide multi-centric association study (Journal of Neurology, (2024), 271, 11, (7250-7263), 10.1007/s00415-024-12608-6) 166
DNA Methylation in the Anti-Mullerian Hormone Gene and the Risk of Disease Activity in Multiple Sclerosis 153
Refractory anti-NMDAR encephalitis successfully treated with bortezomib and associated movements disorders controlled with tramadol: a case report with literature review 153
Vitamin D affects the risk of disease activity in multiple sclerosis 138
Sex hormone-related factors and the risk of PIRA in women with multiple sclerosis 128
Involvement of NINJ2 Protein in Inflammation and Blood-Brain Barrier Transmigration of Monocytes in Multiple Sclerosis 124
Genetic Contribution to Medium-Term Disease Activity in Multiple Sclerosis 118
Pharmacogenomics of clinical response to Natalizumab in multiple sclerosis: a genome-wide multi-centric association study 111
A genetic-epigenetic interplay at 1q21.1 locus underlies CHD1L-mediated vulnerability to primary progressive multiple sclerosis 110
HSV encephalitis associated with off-label rituximab treatment of multiple sclerosis 110
COVID-19: can we learn from encephalitis lethargica? 108
Correction to: Refractory anti‑NMDAR encephalitis successfully treated with bortezomib and associated movements disorders controlled with tramadol: a case report with literature review (Journal of Neurology, (2020), 267, 8, (2462-2468), 10.1007/s00415-020-09988-w) 107
Teaching NeuroImage: Spontaneously Resolving Ring-Enhancing Lesions Due to Immunodeficiency-Associated CNS Lymphoma: A Case of "Vanishing Lymphoma" 106
The Italian law on body donation: A position paper of the Italian College of Anatomists 106
Contribution of Polygenic Scores to Progression Independent of Relapse Activity in Multiple Sclerosis 105
Risk HLA Variants Affect the T-Cell Repertoire in Multiple Sclerosis 104
Assessing seasonal dynamics of Guillain-Barré syndrome with search engine query data 103
Association between inflammatory central nervous system lesions and Cerebellar Ataxia, Neuropathy and Vestibular Areflexia Syndrome (CANVAS): a case series 100
Neuromyelitis optica spectrum disorder and multiple sclerosis in a Sardinian family 98
Circulating MAIT cells in multiple sclerosis and amyotrophic lateral sclerosis 97
Stress related to COVID-19 pandemic as a trigger for disease activity in multiple sclerosis: a case report 93
Diagnosing autoimmune encephalitis in a real-world single-centre setting 92
Digital epidemiology confirms a latitude gradient of MS in France 90
Teaching NeuroImages: Osteolytic intraosseous meningioma causing transcalvarial herniation 85
Early use of fingolimod is associated with better clinical outcomes in relapsing-remitting multiple sclerosis patients 85
Upper limb motor evoked potentials as outcome measure in progressive multiple sclerosis 84
Clinical integration of brain and cord MRI features improves differential diagnosis of multiple sclerosis 79
Progressive visual function impairment as the predominant symptom of the transition phase to secondary progressive multiple sclerosis: A case report 78
Risk attitude and personality in people with multiple sclerosis facing the choice of different disease-modifying therapy scenarios 76
Risk factor profile and infarct size in single subcortical ischemic strokes: a MRI-based single-center study 74
A HIF1A variant impacts long-term disability and smoldering inflammation in multiple sclerosis 70
Environmental risk factors and conversion to multiple sclerosis in subjects with radiologically isolated syndrome: a case–control study 60
The hypoxia-inflammation cycle as a key mechanism of smoldering inflammation and progression in multiple sclerosis 22
Distinct age-related pattern of mitochondrial somatic mutations across multiple sclerosis phenotypes 20
Anti‐CD20 Drugs and Natalizumab Confer Equal Protection Against Progression Independent of Relapse Activity (PIRA) in People With Multiple Sclerosis 15
Pharmacogenomics of response to interferon-beta and glatiramer acetate in Multiple Sclerosis: A multi-centric study 12
Incidence of Progression Independent of Relapse Activity (PIRA) under platform disease-modifying treatment in multiple sclerosis 1
Totale 3.720
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.375
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.375
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202217 0 0 0 5 1 0 1 2 6 0 2 0
2022/2023135 33 28 8 2 4 13 10 17 2 2 9 7
2023/2024177 7 16 18 15 21 14 8 12 0 5 20 41
2024/2025625 55 41 48 28 46 40 83 46 96 31 41 70
2025/20262.160 158 121 132 289 205 50 163 188 573 128 78 75
2026/2027588 81 114 122 271 0 0 0 0 0 0 0 0
Totale 3.720